|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0015811,
umls-concept:C0019557,
umls-concept:C0021665,
umls-concept:C0029453,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0205107,
umls-concept:C0229671,
umls-concept:C0332185,
umls-concept:C0441889,
umls-concept:C0442805,
umls-concept:C0599946,
umls-concept:C0770246
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-5-15
|
|
pubmed:abstractText |
Elderly persons who have osteoporotic hip fracture are often undernourished, particularly with respect to protein. Protein malnutrition may contribute to the occurrence and outcome of hip fracture.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
128
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
801-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9599191-Activities of Daily Living,
pubmed-meshheading:9599191-Aged,
pubmed-meshheading:9599191-Aged, 80 and over,
pubmed-meshheading:9599191-Bone Density,
pubmed-meshheading:9599191-Dietary Proteins,
pubmed-meshheading:9599191-Dietary Supplements,
pubmed-meshheading:9599191-Double-Blind Method,
pubmed-meshheading:9599191-Female,
pubmed-meshheading:9599191-Femur,
pubmed-meshheading:9599191-Follow-Up Studies,
pubmed-meshheading:9599191-Hip Fractures,
pubmed-meshheading:9599191-Humans,
pubmed-meshheading:9599191-Immunoglobulin M,
pubmed-meshheading:9599191-Insulin-Like Growth Factor I,
pubmed-meshheading:9599191-Length of Stay,
pubmed-meshheading:9599191-Male,
pubmed-meshheading:9599191-Osteoporosis,
pubmed-meshheading:9599191-Placebos,
pubmed-meshheading:9599191-Prealbumin,
pubmed-meshheading:9599191-Protein Deficiency,
pubmed-meshheading:9599191-Serum Albumin
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
World Health Organization Collaborating Center for Osteoporosis and Bone Diseases and University Hospital, Geneva, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
